SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

$SLAP is gaining attention, with community members expressing excitement and anticipation for potential gains. Sentiment revolves around the project's progress and future prospects, particularly within the Base network. The community frequently uses the terms '$BROKE', '$RAGE', and '$WAGMI', potentially indicating a shared experience of overcoming challenges and striving for success.

Monero

Monero is trending as community members discuss its potential, use cases, and status as a leading privacy coin. Recent price action and bullish chart patterns have sparked speculation about Monero's future, with some eyeing previous all-time highs, while others believe it is what Bitcoin should have been. The community is also discussing its relative stability compared to other cryptocurrencies and its importance in a world where privacy is increasingly valued.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

CVM is trending amid anticipation for a decision from the Saudi Food and Drug Authority (SFDA) regarding Breakthrough Medicine Designation for Multikine. Community discussions revolve around the potential for expedited approval and market access in Saudi Arabia, a key element of CEL-SCI's strategic roadmap. Some are expressing frustration from the long wait time, while others remain confident in the drug's potential and the partnership with Dallah Pharma.

P8BCI Is the CCM Creator Capital Markets Creator token created by Nick Wray, intended to form a community for talking about his journey with ALS, his experiences with Telepathy BCI experiments, as well as his experiences and journey through the Solana blockchain, and cryptocurrency world of Web 3. In addition to this, prior to his progression of ALS Nick was an avid drummer, a creative, and an enjoyer of philosophical discussion - and enabled now by his BCI explores creating, and in addition to sharing his story, interacting with the community forming around his experiences.

Telepath8

Telepath8 ($P8BCI) is trending as the community rallies around its developer, Nick Wray, and his work on the project. Conversations highlight Wray's background and apparent connections to Neuralink. Some community members suggest these factors are bullish for the crypto's future.

ETF Opportunities Trust - T-REX 2X Long TTD Daily Target ETF

T-REX 2X Long TTD Daily Target ETF

Traders are discussing $TTDU, a 2x leveraged ETF for $TTD, focusing on its potential for amplified gains, especially after what some consider an overreaction to earnings. Community members are weighing the risks and rewards of using leverage, with some citing technical indicators and analyst price targets as bullish signals for $TTD and, by extension, $TTDU.

Direxion Shares ETF Trust - Direxion Daily Homebuilders & Supplies Bull 3X Shares

Direxion Daily Homebuilders & Supplies Bull 3X Shares

The Direxion Daily Homebuilders & Supplies Bull 3X Shares ($NAIL) is trending amid discussions about potential interest rate cuts and their impact on the housing market. Community members are weighing the possibility of a new housing bubble and debating the ETF's future trajectory, with some pointing to technical indicators suggesting a buying opportunity. Recent data on pending home sales and building permits are also factoring into the conversation.

Concordium is the Layer-1 blockchain built for a new era of digital trust. With mandatory, privacy-preserving identity verification built into its consensus layer, utilizing zero-knowledge proof technology. Concordium also enables Protocol-level tokens that eliminate smart contract risks by being issued directly at the consensus layer, with built-in features that provide the infrastructure for compliance-ready use cases. At its core is Smart Money - programmable, identity-embedded, and compliance-ready value that powers trusted interactions across Web3. Smart Money enables frictionless exchange, automation, and verifiable trust by design. Unlike conventional blockchains, Concordium integrates trust, accountability, and privacy into its architecture from the ground up  bridging traditional systems and Web3 to build a transparent, sustainable digital future. The name Concordium comes from the Latin concordia—meaning harmony and agreement—a reflection of its mission to build infrastructure that embeds trust, privacy, and compliance into every interaction.

Concordium

Concordium ($CCD) is trending as discussions highlight its focus on compliance, privacy, and real-world utility, particularly within the PayFi sector. Community members are drawn to Concordium's unique approach to balancing privacy and transparency, suggesting it's positioning itself as a key player in regulated DeFi. The recent partnership with bitcoin.com is also driving bullish sentiment.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is trending amid mixed sentiment as investors debate its valuation, future growth, and potential for a buyout, especially following news of other acquisitions in the biotech space. Community discussions center around the company's revenue projections, profitability, and whether management will consider a deal, while others are closely watching technical indicators and potential market manipulation.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending following positive Phase 1 data for its CTX310 therapy, showcasing significant cholesterol and triglyceride reduction with a one-time treatment. The community is excited about the potential for a single-dose solution to lifelong lipid disorders, with some anticipating blockbuster potential and future applications in diabetes and cancer.

Mantle

Mantle is seeing volatile price action, sparking heated discussions around resistance levels and perceived manipulation. The community is closely watching for potential breakouts while reacting to news around ecosystem developments and rewards programs. Recent integrations with Chainlink and EigenLayer, coupled with new DeFi initiatives, are also driving interest in Mantle's potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

3,243 Shares in The Hartford Insurance Group, Inc. $HIG Acquired by HORAN Wealth LLC

HORAN Wealth LLC bought a new position in shares of The Hartford Insurance Group, Inc. (NYSE:HIG - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities...

Sienna Gestion Has $7.48 Million Stock Holdings in The Hartford Insurance Group, Inc. $HIG

Sienna Gestion increased its position in The Hartford Insurance Group, Inc. (NYSE:HIG - Free Report) by 9.8% in the 2nd quarter, according to the company in its most recent 13F filing with the...

Can AON Beat Q3 Earnings on Commercial Risk Solutions Strength?

AON aims for another earnings beat as growth in Commercial Risk Solutions and solid segmental gains drive Q3 momentum.

HIG Q3 Earnings Beat Estimates on Personal Insurance Unit Strength

Hartford's Q3 earnings rise 49% YoY as strong Personal Insurance and investment income fuel a solid top- and bottom-line beat.

Compared to Estimates, The Hartford Insurance Group (HIG) Q3 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for The Hartford Insurance Group (HIG) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

The Hartford Announces Record Third Quarter Earnings

The Hartford (NYSE: HIG) today announced financial results for the third quarter ended Sept. 30, 2025. The Hartford delivered outstanding third quarter results, generating record core earnings of...

Will A Strong Personal Insurance Unit Aid The Hartford's Q3 Earnings? 

HIG's Q3 results are likely to get a boost from Personal Insurance and Employee Benefits units' growth, but rising costs could weigh on margins.

Unlocking Q3 Potential of The Hartford Insurance Group (HIG): Exploring Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for The Hartford Insurance Group (HIG), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

Arch Capital Group (ACGL) Reports Next Week: Wall Street Expects Earnings Growth

Arch Capital (ACGL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Startup home insurance company expands into risky states

Homeowners' insurance has become extremely difficult to secure in the highest climate-risk states, such as California, Florida, and Texas.And the problem continues to grow, as more than one-fourth of...

The Hartford Insurance Group, Inc. is an insurance and financial services company. It operates through the following segments: Commercial Lines, Personal Lines, Property & Casualty Other Operations, Group Benefits, Hartford Funds, and Corporate. The Commercial Lines segment provides workers' compensation, property, automobile, liability and umbrella coverage under several different products. The Personal Lines segment offers standard automobile, homeowners, and personal umbrella coverage to individuals. The Property & Casualty Other Operations segment includes certain property and casualty operations, managed by the company, that have discontinued writing new business and substantially all of the company's asbestos and environmental exposures. The Group Benefits segment provides group life, accident, and disability coverage, as well as group retiree health and voluntary benefits. The Hartford Funds segment offers investment products for retail and retirement accounts and provides investment management and administrative services. The Corporate segment includes corporate category discontinued operations, reserves for run-off structured settlement, and terminal funding agreement liabilities, restructuring costs, and capital raising activities. The company was founded by Terry Nathaniel on May 10, 1810, and is headquartered in Hartford, CT.

Hartford Insurance Group Inc.(The)

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$129.41
Prev Close	$127.94
Open	$128.34
Dividend Yield	1.76%
50-Day Moving Average	$129.51
Beta	0.59
Avg. Volume	1.55M
PE Ratio	10.57

52-Week High	$135.17
52-Week Low	$104.93
Market Capitalization	$36.06B
EPS (Annual)	$10.35
Price to Book	2.00
Revenue Per Employee	$1.39M
Enterprise Value/EBITDA	N/A

HIG
Hartford Financial Services Group Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HIG News

HIGHartford Financial Services Group Inc.